Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.

Zielonka D, Ren M, De Michele G, Roos RAC, Squitieri F, Bentivoglio AR, Marcinkowski JT, Landwehrmeyer GB.

Parkinsonism Relat Disord. 2018 Apr;49:42-47. doi: 10.1016/j.parkreldis.2018.01.006. Epub 2018 Jan 5.

PMID:
29326033
2.

Clinical manifestations of intermediate allele carriers in Huntington disease.

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network.

Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8.

PMID:
27402890
3.

Behavioural abnormalities contribute to functional decline in Huntington's disease.

Hamilton JM, Salmon DP, Corey-Bloom J, Gamst A, Paulsen JS, Jerkins S, Jacobson MW, Peavy G.

J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):120-2.

4.

Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.

Goh AM, Wibawa P, Loi SM, Walterfang M, Velakoulis D, Looi JC.

Australas Psychiatry. 2018 Aug;26(4):366-375. doi: 10.1177/1039856218791036. Epub 2018 Jul 16. Review.

PMID:
30012004
5.

The influence of gender on phenotype and disease progression in patients with Huntington's disease.

Zielonka D, Marinus J, Roos RA, De Michele G, Di Donato S, Putter H, Marcinkowski J, Squitieri F, Bentivoglio AR, Landwehrmeyer GB.

Parkinsonism Relat Disord. 2013 Feb;19(2):192-7. doi: 10.1016/j.parkreldis.2012.09.012. Epub 2012 Oct 25.

PMID:
23102616
6.

Rate of functional decline in Huntington's disease. Huntington Study Group.

Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB Jr, Siemers E, Shoulson I.

Neurology. 2000 Jan 25;54(2):452-8. Erratum in: Neurology 2000 Apr 25;54(8):1712.

PMID:
10668713
7.

The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.

Van Liew C, Gluhm S, Goldstein J, Cronan TA, Corey-Bloom J.

Psychiatry. 2013 Winter;76(4):323-35. doi: 10.1521/psyc.2013.76.4.323.

PMID:
24299091
8.

Clinical characterization of dystonia in adult patients with Huntington's disease.

van de Zande NA, Massey TH, McLauchlan D, Pryce Roberts A, Zutt R, Wardle M, Payne GC, Clenaghan C, Tijssen MAJ, Rosser AE, Peall KJ.

Eur J Neurol. 2017 Sep;24(9):1140-1147. doi: 10.1111/ene.13349. Epub 2017 Jun 29.

PMID:
28661018
9.

An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.

Vaccarino AL, Anderson K, Borowsky B, Duff K, Giuliano J, Guttman M, Ho AK, Orth M, Paulsen JS, Sills T, van Kammen DP, Evans KR; PREDICT-HD and REGISTRY Investigators Coordinators.

Mov Disord. 2011 Apr;26(5):877-84. doi: 10.1002/mds.23574. Epub 2011 Mar 2.

10.

Effectiveness of intensive neurorehabilitation in patients with Huntington's disease.

Ciancarelli I, Tozzi Ciancarelli MG, Carolei A.

Eur J Phys Rehabil Med. 2013 Apr;49(2):189-95. Epub 2013 Mar 13.

11.

Everyday Functioning in Huntington's Disease: A Laboratory-Based Study of Financial Management Capacity.

Sheppard DP, Pirogovsky-Turk E, Woods SP, Holden HM, Nicoll DR, Filoteo JV, Corey-Bloom J, Gilbert PE.

Appl Neuropsychol Adult. 2017 Mar-Apr;24(2):176-182. doi: 10.1080/23279095.2015.1125904. Epub 2016 Apr 14.

PMID:
27077945
12.

Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.

Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2016 Oct;31(10):1466-1478. doi: 10.1002/mds.26675. Review.

PMID:
27296904
13.

Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.

Youssov K, Dolbeau G, Maison P, Boissé MF, Cleret de Langavant L, Roos RA, Bachoud-Lévi AC.

Mov Disord. 2013 Oct;28(12):1717-23. doi: 10.1002/mds.25654.

14.

The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.

Youssov K, Dolbeau G, Maison P, Boissé MF, Cleret de Langavant L, Roos RA, Bachoud-Lévi AC.

Mov Disord. 2013 Dec;28(14):1995-2001. doi: 10.1002/mds.25678. Epub 2013 Oct 9.

PMID:
24123464
15.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ.

Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Erratum in: Lancet Neurol. 2017 Sep;16(9):683.

PMID:
28642124
16.

Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.

Kloos AD, Kegelmeyer DA, Fritz NE, Daley AM, Young GS, Kostyk SK.

J Huntingtons Dis. 2017;6(4):363-370. doi: 10.3233/JHD-170279.

17.

Motor-cognitive dual-task deficits in individuals with early-mid stage Huntington disease.

Fritz NE, Hamana K, Kelson M, Rosser A, Busse M, Quinn L.

Gait Posture. 2016 Sep;49:283-289. doi: 10.1016/j.gaitpost.2016.07.014. Epub 2016 Jul 17.

PMID:
27474949
18.

Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.

Gonzalez V, Cif L, Biolsi B, Garcia-Ptacek S, Seychelles A, Sanrey E, Descours I, Coubes C, de Moura AM, Corlobe A, James S, Roujeau T, Coubes P.

J Neurosurg. 2014 Jul;121(1):114-22. doi: 10.3171/2014.2.JNS131722. Epub 2014 Apr 4.

PMID:
24702329
19.

Unified Huntington's disease rating scale: clinical practice and a critical approach.

Klempír J, Klempírova O, Spacková N, Zidovská J, Roth J.

Funct Neurol. 2006 Oct-Dec;21(4):217-21.

PMID:
17367582
20.

Bradykinesia in early Huntington's disease.

Sánchez-Pernaute R, Künig G, del Barrio Alba A, de Yébenes JG, Vontobel P, Leenders KL.

Neurology. 2000 Jan 11;54(1):119-25.

PMID:
10636136

Supplemental Content

Support Center